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Underreporting child abuse deaths: 
Not all is rosy with PinkDrive
To the Editor: The Breast Interest Group of Southern Africa would 
like to respond to a recent article in the SAMJ[1] regarding the 
activities of PinkDrive in the Western Cape and KwaZulu-Natal. 
Members of the group who were quoted in the article wish to put on 
record that these quotes were unauthorised and that they dissociate 
themselves from the content of the article.
The gist of the article was that a mobile mammography unit 
operated by PinkDrive had greatly assisted the public sector by 
providing mobile mammography services at public health facilities, 
so ‘potentially saving thousands of lives’. This statement is misleading 
and not based on fact. In the Western Cape, after several thousand 
women had screening mammograms, the mammographic screening 
activities of PinkDrive had to be stopped owing to poor imaging 
quality, poor interpretation of mammograms, and lack of provision 
for work-up of positive findings. Referral hospitals were forced to 
take corrective action. Similar problems were encountered during a 
short stay of the PinkDrive screening unit in KwaZulu-Natal.
The Breast Interest Group of Southern Africa supports 
mammographic screening that adheres to scientifically sound 
principles. PinkDrive’s screening model violated numerous of these 
principles. Contrary to service level agreements, it never operated 
under any scientific scrutiny. The assumption underlying PinkDrive’s 
screening operation (that providing mammography services would 
solve the challenges of breast cancer services provision in South 
Africa) is erroneous and therefore counter-productive. The definitive 
diagnosis of breast cancer is not made by mammography but by 
pathologic examination of a tissue sample from a tumour. Specimen 
acquisition and pathology services are problematic nationally. For 
example, in the Western Cape, cytology samples of breast masses in 
peripheral clinics have a less than 40% adequacy rate, and waiting 
times for cytopathology results currently exceed 1 month. This leads 
to several patient visits to service points and long delays in making 
a diagnosis. The Breast Interest Group of Southern Africa strongly 
advises that specimen acquisition and pathology services be improved 
nationally. Models for such improvement have been developed and 
implemented in the Western Cape and elsewhere but are thwarted by 
lack of resources. It is here that NGOs such as PinkDrive can make 
a valuable contribution. Once diagnosis has been made, access to 
treatment is equally problematic, with waiting times for surgery and 
radiotherapy in many units exceeding 3 months. The Breast Interest 
Group of Southern Africa strongly advocates that capacity in surgical, 
medical and radiation oncology services be increased urgently to 
catch up with the rapidly rising cancer burden in the public sector. 
A more than tripling of the caseload in breast cancer at a major 
teaching hospital over the last 15 years also requires a commensurate 
increase in resources for treatment; treatment capacity, however, has 
not changed.
The Breast Interest Group of Southern Africa welcomes the 
involvement of NGOs in alleviating service provision challenges 
in the public sector. Such involvement must, however, tie in with 
existing services, be scientifically sound, and achieve defined goals. 
In the light of the major challenges outlined above, it is extremely 
unwise to divert scarce resources into poorly designed and 
scientifically unsound mobile screening mammography services.
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